{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:20:17Z","timestamp":1792020017030,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2009050"],"award-info":[{"award-number":["2009050"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s10620-025-08906-2","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T04:24:09Z","timestamp":1740025449000},"page":"1486-1494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Annual Blood Tests Are an Acceptable form of Surveillance to Supplement Colonoscopies for Colorectal Cancer"],"prefix":"10.1007","volume":"70","author":[{"given":"Rishabh","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlene J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid H.","family":"Flight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molla M.","family":"Wassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cohen-Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Symonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddison","family":"Dix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"8906_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338\u2013344.","journal-title":"Gut."},{"key":"8906_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u2013249.","journal-title":"CA Cancer J Clin."},{"key":"8906_CR3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10620-015-3600-5","volume":"60","author":"AG Zauber","year":"2015","unstructured":"Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60:681\u2013691. 10.1007\/s10620-015-3600-5","journal-title":"Dig Dis Sci."},{"key":"8906_CR4","doi-asserted-by":"crossref","unstructured":"Syngal S, Bandipalliam P, Boland CR. Surveillance of patients at high risk for colorectal cancer. Med Clin North Am. 2005;89:61\u201384, vii\u2013viii.","DOI":"10.1016\/j.mcna.2004.08.013"},{"key":"8906_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5217\/ir.2023.00107","volume":"21","author":"YS Jung","year":"2023","unstructured":"Jung YS. Summary and comparison of recently updated post-polypectomy surveillance guidelines. Intest Res. 2023;21:443\u2013451.","journal-title":"Intest Res."},{"key":"8906_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11606-014-3015-6","volume":"30","author":"GR Kruse","year":"2015","unstructured":"Kruse GR, Khan SM, Zaslavsky AM, Ayanian JZ, Sequist TD. Overuse of colonoscopy for colorectal cancer screening and surveillance. J Gen Intern Med. 2015;30:277\u2013283.","journal-title":"J Gen Intern Med."},{"key":"8906_CR7","doi-asserted-by":"crossref","first-page":"e82676","DOI":"10.1371\/journal.pone.0082676","volume":"8","author":"C Stock","year":"2013","unstructured":"Stock C, Holleczek B, Hoffmeister M, Stolz T, Stegmaier C, Brenner H. Adherence to physician recommendations for surveillance in opportunistic colorectal cancer screening: the necessity of organized surveillance. PLoS One. 2013;8:e82676.","journal-title":"PLoS One."},{"key":"8906_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/09691413211056777","volume":"29","author":"F van Wifferen","year":"2022","unstructured":"van Wifferen F, de Jonge L, Worthington J et al. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: a comparative modelling study. J Med Screen. 2022;29:72\u201383.","journal-title":"J Med Screen."},{"key":"8906_CR9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10620-014-3445-3","volume":"60","author":"GP Young","year":"2015","unstructured":"Young GP, Symonds EL, Allison JE et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60:609\u2013622. 10.1007\/s10620-014-3445-3","journal-title":"Dig Dis Sci."},{"key":"8906_CR10","doi-asserted-by":"crossref","unstructured":"Wassie MM, Young GP, Winter JM, et al. Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program. Clin Gastroenterol Hepatol. 2023;21:2389\u20132398 e2.","DOI":"10.1016\/j.cgh.2022.12.024"},{"key":"8906_CR11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/jgh.15823","volume":"37","author":"MM Wassie","year":"2022","unstructured":"Wassie MM, Young GP, Cock C et al. Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia. J Gastroenterol Hepatol. 2022;37:1067\u20131075.","journal-title":"J Gastroenterol Hepatol."},{"key":"8906_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/M16-2891","volume":"167","author":"MJE Greuter","year":"2017","unstructured":"Greuter MJE, de Klerk CM, Meijer GA, Dekker E, Coupe VMH. Screening for colorectal cancer with fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy: a cost-effectiveness analysis. Ann Intern Med. 2017;167:544\u2013554.","journal-title":"Ann Intern Med."},{"key":"8906_CR13","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s10620-024-08466-x","volume":"69","author":"MM Wassie","year":"2024","unstructured":"Wassie MM, Dix M, Laven-Law G et al. Accuracy, acceptability, and application: fecal immunochemical tests for early detection of advanced neoplasia in colonoscopy-based surveillance. Dig Dis Sci. 2024;69:2621\u20132630. 10.1007\/s10620-024-08466-x","journal-title":"Dig Dis Sci."},{"key":"8906_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0969141315584694","volume":"22","author":"C Klabunde","year":"2015","unstructured":"Klabunde C, Blom J, Bulliard JL et al. Participation rates for organized colorectal cancer screening programmes: an international comparison. J Med Screen. 2015;22:119\u2013126.","journal-title":"J Med Screen."},{"key":"8906_CR15","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.14309\/01.ajg.0000950820.05087.2c","volume":"118","author":"V Raymond","year":"2023","unstructured":"Raymond V, Foster G, Hong Y et al. S295 implementation of blood-based colorectal cancer screening: real-world clinical experience [Abstract]. Am J Gastroenterol. 2023;118:S218.","journal-title":"Am J Gastroenterol."},{"key":"8906_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctarc.2016.12.004","volume":"10","author":"EG Liles","year":"2017","unstructured":"Liles EG, Coronado GD, Perrin N et al. Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic: a randomized trial. Cancer Treat Res Commun. 2017;10:27\u201331.","journal-title":"Cancer Treat Res Commun."},{"key":"8906_CR17","unstructured":"Guardant Health. Guardant Health\u2019s Shield\u2122 Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening. Available from: https:\/\/investors.guardanthealth.com\/press-releases\/press-releases\/2024\/Guardant-Healths-Shield-Blood-Test-Approved-by-FDA-as-a-Primary-Screening-Option-Clearing-Path-for-Medicare-Reimbursement-and-a-New-Era-of-Colorectal-Cancer-Screening\/default.aspx. Accessed Aug 8, 2024."},{"key":"8906_CR18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/mja17.00823","volume":"208","author":"EL Symonds","year":"2018","unstructured":"Symonds EL, Simpson K, Coats M et al. A nurse-led model at public academic hospitals maintains high adherence to colorectal cancer surveillance guidelines. Med J Aust. 2018;208:492\u2013496.","journal-title":"Med J Aust."},{"key":"8906_CR19","unstructured":"Cancer Council Australia Colorectal Cancer Screening Working Party. Risk and screening based on family history. In: Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Sydney, AU: Cancer Council Australia; 2023. Available from: https:\/\/cancer.org.au\/clinical-guidelines\/bowel-cancer\/colorectal-cancer. Accessed Aug 15, 2024."},{"key":"8906_CR20","unstructured":"Cancer Council Australia Surveillance Colonoscopy Guidelines Working Party. Clinical practice guidelines for surveillance colonoscopy. Sydney, AU: Cancer Council Australia; 2018. Available from: https:\/\/cancer.org.au\/clinical-guidelines\/bowel-cancer\/surveillance-colonoscopy. Accessed Aug 8, 2024."},{"key":"8906_CR21","first-page":"e13713","volume":"31","author":"M Dix","year":"2022","unstructured":"Dix M, Wilson CJ, Flight IH et al. Patient attitudes towards changes in colorectal cancer surveillance: an application of the health belief model. Eur J Cancer Care (Engl). 2022;31:e13713.","journal-title":"Eur J Cancer Care (Engl)."},{"key":"8906_CR22","unstructured":"Australian Bureau of Statistics. 2033.0.55.001 - Census of population and housing: socio-economic indexes for areas (SEIFA), Australia, 2016. Available from: https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/mf\/2033.0.55.001. Accessed Aug 8, 2024."},{"key":"8906_CR23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/109019818801500203","volume":"15","author":"IM Rosenstock","year":"1988","unstructured":"Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15:175\u2013183.","journal-title":"Health Educ Q."},{"key":"8906_CR24","first-page":"1091","volume":"67","author":"LA Anderson","year":"1990","unstructured":"Anderson LA, Dedrick RF. Development of the trust in physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990;67:1091\u20131100.","journal-title":"Psychol Rep."},{"key":"8906_CR25","unstructured":"IBM Corp. IBM SPSS Statistics for windows. Version 29.0. Armonk, NY: IBM Corp; 2023."},{"key":"8906_CR26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/1753-6405.12523","volume":"40","author":"IT Zajac","year":"2016","unstructured":"Zajac IT, Duncan A, Turnbull D, Wilson C, Flight I. Blood-based screening for bowel cancer may not resolve suboptimal screening participation in Australia. Aust N Z J Public Health. 2016;40:337\u2013341.","journal-title":"Aust N Z J Public Health."},{"key":"8906_CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/09691413221109999","volume":"30","author":"O Ali","year":"2023","unstructured":"Ali O, Gupta S, Brain K, Lifford KJ, Paranjothy S, Dolwani S. Acceptability of alternative technologies compared with faecal immunochemical test and\/or colonoscopy in colorectal cancer screening: a systematic review. J Med Screen. 2023;30:14\u201327.","journal-title":"J Med Screen."},{"key":"8906_CR28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/jgh.16531","volume":"39","author":"G Laven-Law","year":"2024","unstructured":"Laven-Law G, Symonds EL, Winter JM et al. Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherence. J Gastroenterol Hepatol. 2024;39:1267\u20131276.","journal-title":"J Gastroenterol Hepatol."},{"key":"8906_CR29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2147\/PPA.S172143","volume":"12","author":"JM Osborne","year":"2018","unstructured":"Osborne JM, Flight I, Wilson CJ, Chen G, Ratcliffe J, Young GP. The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens. Patient Prefer Adherence. 2018;12:1825\u20131836.","journal-title":"Patient Prefer Adherence."},{"key":"8906_CR30","doi-asserted-by":"crossref","first-page":"101223","DOI":"10.1016\/j.pmedr.2020.101223","volume":"20","author":"J Lau","year":"2020","unstructured":"Lau J, Lim TZ, Jianlin Wong G, Tan KK. The health belief model and colorectal cancer screening in the general population: a systematic review. Prev Med Rep. 2020;20:101223.","journal-title":"Prev Med Rep."},{"key":"8906_CR31","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.116762","volume":"347","author":"N Schmeising-Barnes","year":"2024","unstructured":"Schmeising-Barnes N, Waller J, Marlow LAV. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: a qualitative study in great britain. Soc Sci Med. 2024;347:116762.","journal-title":"Soc Sci Med."},{"key":"8906_CR32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11606-010-1304-2","volume":"25","author":"JM Griffin","year":"2010","unstructured":"Griffin JM, Partin MR, Noorbaloochi S et al. Variation in estimates of limited health literacy by assessment instruments and non-response bias. J Gen Intern Med. 2010;25:675\u2013681.","journal-title":"J Gen Intern Med."},{"key":"8906_CR33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5993\/AJHB.38.3.4","volume":"38","author":"JM Taber","year":"2014","unstructured":"Taber JM, Aspinwall LG, Heichman KA, Kinney AY. Preferences for blood-based colon cancer screening differ by race\/ethnicity. Am J Health Behav. 2014;38:351\u2013361.","journal-title":"Am J Health Behav."},{"key":"8906_CR34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa2304714","volume":"390","author":"DC Chung","year":"2024","unstructured":"Chung DC, Gray DM, Singh H et al. A cell-free DNA blood-based test for colorectal cancer screening. N Engl J Med. 2024;390:973\u2013983.","journal-title":"N Engl J Med."},{"key":"8906_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7326\/M13-1484","volume":"160","author":"JK Lee","year":"2014","unstructured":"Lee JK, Liles EG, Bent S et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160:171\u2013181.","journal-title":"Ann Intern Med."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-08906-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T01:50:50Z","timestamp":1743904250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-08906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["8906"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-08906-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest that are currently relevant to this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}